Itschak Shrem Biography and Net Worth

Director of SciSparc

Mr. Shrem is our Chairman, he has served as our President since January 2022 and on our Board of Directors since August 2020. Mr. Shrem has our Chairman between August 2020 and January 2021 and brings more than 40 years of experience in financial markets and venture capital. In 1991, Mr. Shrem founded Dovrat Shrem Ltd., an investment banking, management and technology company. Prior to that, he spent 15 years at Clal Israel Ltd., where he served in various capacities, including chief operating officer, and was responsible for capital markets and insurance businesses. In 1993, Mr. Shrem founded Pitango Venture Capital Fund (formerly, Polaris) and served as a partner of Pitango Funds I, II and III. He has been the Managing Director of Yaad Consulting 1995 Ltd. since 1995.

Mr. Shrem currently serves on the board of directors of Rail Visions Ltd. and has previously served on the board of Tel-Aviv Sourasky Medical Center, the Weizman Institute Eden Spring Ltd., Nano Dimension Ltd., Ormat Industries Ltd., Retalix Ltd. and as Chairman of Sphera Funds Management Ltd. Mr. Shrem holds a B.A in Economics and Accounting from Bar-Ilan University and an M.B.A. from Tel-Aviv University.

What is Itschak Shrem's net worth?: The estimated net worth of Itschak Shrem is at least $46.15 thousand as of June 1st, 2026. Shrem owns 10,596 shares of SciSparc stock worth more than $46,146 as of October 9th. This net worth estimate does not reflect any other investments that Shrem may own. Learn More about Itschak Shrem's net worth.
How do I contact Itschak Shrem?: The corporate mailing address for Shrem and other SciSparc executives is 20 RAUL WALLENBERG STREET TOWER A, TEL AVIV L3, 6971916. SciSparc can also be reached via phone at 972-3717-5777 and via email at [email protected]. Learn More on Itschak Shrem's contact information.
Has Itschak Shrem been buying or selling shares of SciSparc?: Itschak Shrem has not been actively trading shares of SciSparc over the course of the past ninety days. Most recently, Itschak Shrem sold 462 shares of the business's stock in a transaction on Monday, June 1st. The shares were sold at an average price of $10.00, for a transaction totalling $4,620.00. Following the completion of the sale, the director now directly owns 10,596 shares of the company's stock, valued at $105,960. Learn More on Itschak Shrem's trading history.
Are insiders buying or selling shares of SciSparc?: During the last year, insiders at the sold shares 1 times. They sold a total of 462 shares worth more than $4,620.00. The most recent insider tranaction occured on June, 1st when Director Itschak Shrem sold 462 shares worth more than $4,620.00. Insiders at SciSparc own 1.5% of the company. Learn More about insider trades at SciSparc.
Information on this page was last updated on 6/1/2026.

Itschak Shrem Insider Trading History at SciSparc

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/1/2026	Sell	462	$10.00	$4,620.00	10,596

Itschak Shrem Buying and Selling Activity at SciSparc

SciSparc Company Overview

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Today's Range

Now: $4.35

$4.29

$4.60

50 Day Range

MA: $5.70

$4.33

$7.16

2 Week Range

Now: $4.35

$2.98

$43.65

Volume

4,555 shs

Average Volume

463,331 shs

Market Capitalization

$2.48 million

P/E Ratio

N/A

Dividend Yield